2010 - Member of the National Academy of Medicine (NAM)
His primary scientific interests are in Economic evaluation, Health care, Cost–benefit analysis, Health technology and Actuarial science. His Economic evaluation research is multidisciplinary, incorporating perspectives in Psychological intervention, Health economics, Public economics and Public relations. A large part of his Health care studies is devoted to Health policy.
The Cost–benefit analysis study combines topics in areas such as Resource allocation, MEDLINE, Decision tree, Cost-effectiveness analysis and Decision analysis. Michael Drummond usually deals with Health technology and limits it to topics linked to Risk analysis and Order. His Actuarial science research is multidisciplinary, relying on both Activity-based costing, Operations management, Added value, Value of life and Discounting.
Michael Drummond mainly focuses on Economic evaluation, Health care, Health economics, Health technology and Actuarial science. As part of one scientific family, Michael Drummond deals mainly with the area of Economic evaluation, narrowing it down to issues related to the Clinical trial, and often Randomized controlled trial. Michael Drummond works on Health care which deals in particular with Health policy.
As a member of one scientific family, Michael Drummond mostly works in the field of Health economics, focusing on MEDLINE and, on occasion, Family medicine. His Health technology research includes elements of Risk analysis, Reimbursement, Excellence and Value. His study ties his expertise on Quality-adjusted life year together with the subject of Actuarial science.
Health technology, Economic evaluation, Health economics, Health care and Reimbursement are his primary areas of study. His Health technology study incorporates themes from Economic model, Operations management, Grey literature, Risk analysis and Process management. As a part of the same scientific family, Michael Drummond mostly works in the field of Risk analysis, focusing on Health policy and, on occasion, Clinical trial.
His research on Economic evaluation also deals with topics like
Michael Drummond focuses on Health care, Economic evaluation, Health economics, Health technology and Reimbursement. The study incorporates disciplines such as Emerging markets, Actuarial science, Risk analysis and Clinical trial in addition to Health care. His Risk analysis study combines topics in areas such as Psychological intervention, Warrant, Cost–benefit analysis and Health policy.
Borrowing concepts from Resource consumption, he weaves in ideas under Economic evaluation. Michael Drummond has researched Health economics in several fields, including Public finance, Public economics, Process management and Identification. The concepts of his Reimbursement study are interwoven with issues in Demographic economics, Quality-adjusted life year, Quality of life, EQ-5D and Gross domestic product.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Methods for the Economic Evaluation of Health Care Programmes
Michael F. Drummond;Mark J. Sculpher;Karl Claxton;Greg L. Stoddart.
Research Papers in Economics (2015)
Methods for the Economic Evaluation of Health Care Programmes
Michael F. Drummond.
(1987)
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
Don Husereau;Michael Drummond;Stavros Petrou;Chris Carswell.
European Journal of Health Economics (2013)
Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party.
M F Drummond;T O Jefferson.
BMJ (1996)
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
Don Husereau;Don Husereau;Michael F Drummond;Stavros Petrou;Chris Carswell.
Value in Health (2013)
Decision Making in Health and Medicine: Integrating Evidence and Values
M. G Myriam Hunink;Milton C. Weinstein;Eve Wittenberg;Michael F. Drummond.
(2014)
Users' Guides to the Medical Literature: I. How to Get Started
Andrew D. Oxman;David L. Sackett;Gordon H. Guyatt;George Browman.
JAMA (1993)
Economic Evaluation in Health Care: Merging Theory with Practice
Alistair McGuire;Michael Drummond.
(2002)
Modelling in economic evaluation: an unavoidable fact of life.
Martin J. Buxton;Michael F. Drummond;Ben A. Van Hout;Richard L. Prince.
Health Economics (1997)
Cost-of-illness studies: a major headache?
Michael Drummond.
PharmacoEconomics (1992)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Office Of Health Economics
Harvard University
University of Warwick
University of York
Stockholm School of Economics
Tufts University
University of London
Bond University
Harvard University
University of Ottawa
UMIT TIROL - Private University for Health Sciences and Health Technology
Publications: 87
Institute of Automation, Chinese Academy of Sciences
Ball State University
ESPCI Paris
East China Normal University
Central South University
University of Clermont Auvergne
Wageningen University & Research
Utrecht University
University of Geneva
Cardiff University
Sapienza University of Rome
Netherlands Institute for Neuroscience
University of Hong Kong
University of Chicago
Swinburne University of Technology
University of Leeds